ACA
AURA icon

Acorn Capital Advisors’s Aura Biosciences AURA Stock Holding History

Acorn Capital Advisors’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.99M Hold
595,744
– – 1.13% 14
2025
Q4 		$3.25M Hold
595,744
– – 1.1% 15
2025
Q3 		$3.68M Hold
595,744
– – 1.87% 13
2025
Q2 		$3.73M Buy
595,744
+5,236
+0.9% +$30.6K 2.44% 13
2025
Q1 		$1.45M Buy
+590,508
New +$4.47M 0.97% 18

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Acorn Capital Advisors's AURA Position: Q1 2026 in Review

Acorn Capital Advisors held its Aura Biosciences (AURA) position steady in Q1 2026 at 595,744 shares worth $3.99M. The position accounts for 1.13% of the portfolio, ranked #14.

Acorn Capital Advisors first reported a position in AURA in Q1 2025 and has held it in 5 quarters since. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Acorn Capital Advisors held 595,744 shares of Aura Biosciences worth $3.99M as of Q1 2026.
  • Acorn Capital Advisors left its Aura Biosciences share count unchanged in Q1 2026.
  • Aura Biosciences made up 1.13% of Acorn Capital Advisors's portfolio in Q1 2026, its #14 holding.
  • Acorn Capital Advisors first reported a position in Aura Biosciences in Q1 2025 and has held it in 5 quarters since.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Acorn Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.